Compare SAIC & STVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SAIC | STVN |
|---|---|---|
| Founded | 1969 | 1949 |
| Country | United States | Italy |
| Employees | N/A | N/A |
| Industry | EDP Services | Containers/Packaging |
| Sector | Technology | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.4B | 5.7B |
| IPO Year | 2013 | 2021 |
| Metric | SAIC | STVN |
|---|---|---|
| Price | $135.63 | $19.36 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 14 |
| Target Price | ★ $132.70 | $24.47 |
| AVG Volume (30 Days) | ★ 365.0K | 316.8K |
| Earning Date | 08-31-2026 | 11-05-2026 |
| Dividend Yield | ★ 1.14% | 0.33% |
| EPS Growth | ★ 7.39 | N/A |
| EPS | ★ 5.00 | N/A |
| Revenue | ★ $7,262,000,000.00 | N/A |
| Revenue This Year | $0.49 | $7.05 |
| Revenue Next Year | $1.37 | $9.23 |
| P/E Ratio | ★ $25.94 | $27.15 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $81.08 | $12.89 |
| 52 Week High | $142.66 | $27.99 |
| Indicator | SAIC | STVN |
|---|---|---|
| Relative Strength Index (RSI) | 61.65 | 33.93 |
| Support Level | $123.20 | $18.87 |
| Resistance Level | $135.68 | $19.41 |
| Average True Range (ATR) | 3.93 | 0.75 |
| MACD | -0.11 | -0.24 |
| Stochastic Oscillator | 93.62 | 11.34 |
Science Applications International Corp provides technical, engineering, and enterprise IT services mainly to the U.S. government. Specifically, it offers end-to-end solutions spanning the design, development, integration, deployment, management, operations, sustainment, and security of the customer's entire IT infrastructure. The company has two reportable segments, which include Defense and Intelligence and the Civilian segment. Maximum revenue is generated from its Defense and Intelligence segment, which provides a diverse portfolio of national security solutions to the DoW and the Intelligence Community of the United States Government. The Civilian segment provides solutions to the civilian markets, encompassing federal, state, and local governments.
Stevanato Group is a provider of glass and polymer drug containment, drug delivery, and diagnostic solutions to the pharmaceutical and life sciences industries. The company operates through two segments: a Biopharmaceutical and Diagnostic Solutions segment, which offers an integrated, end-to-end portfolio of products, processes, and services spanning the full drug lifecycle; and an Engineering segment, which designs, develops, and manufactures advanced machinery for pharmaceutical manufacturing, covering visual inspection, assembly and packaging, glass converting, and serialization. Stevanato's revenue is geographically diversified, with approximately 60% of sales generated in Europe, the Middle East, and Africa, 30% in North America, 8% in Asia-Pacific, and 2% in South America.